Building on dendritic cell subsets to improve cancer vaccines
/in Dendritic Cells, International PublicationsIncreased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International PublicationsToll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
/in Dendritic Cells, International PublicationsThe evolving role of dendritic cells in cancer therapy
/in Dendritic Cells, International PublicationsFine-tuning immune surveillance by fever-range thermal stress
/in Hyperthermia, International PublicationsDiverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia
/in Hyperthermia, International PublicationsNew perspectives in cancer virotherapy: bringing the immune system into play
/in International Publications, Newcastle Disease VirusDendritic Cells-based Vaccine and Immune Monitoring for Hepatocellular Carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsDendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice
/in Breast Cancer, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer